Are adiponectin levels associated with incident hypertension in normotensive adults?
Higher adiponectin levels are associated with a reduced risk of incident hypertension, independent of body fat distribution.
Abstract Background Excess adipose tissue has been implicated in the pathogenesis of insulin resistance and atherosclerosis and is a key risk factor for blood pressure (BP) elevation. However, circulating levels of adiponectin, a protein produced by adipose tissue and widely implicated in the pathogenesis of insulin resistance and atherosclerosis, are inversely proportional to adiposity. The relationship between adiponectin and incident hypertension has not been determined in the general US population. Methods Normotensive participants (n = 1233) enrolled in the Dallas Heart Study, a multiethnic, probability‐based population sample of Dallas County adults were followed for median of 7 years. Retroperitoneal, intraperitoneal, visceral, and subcutaneous adipose tissue were measured at baseline by magnetic resonance imaging. Liver fat content was measured by 1 H‐magnetic resonance spectroscopy. Relative risk regression was used to determine the association of adiponectin with incident hypertension after adjustment for age, race, sex, BMI, smoking, diabetes, baseline systolic BP, total cholesterol, and regional fat depot. Results Of the 1233 study participants (median age 40 years, 40% black, and 56% women), 391 (32%) had developed hypertension over a median follow‐up of 7 years. Adiponectin levels were associated with reduced risk of incident hypertension (RR 0.81, 95% CI 0.68‐0.96) in the fully adjusted model, which included liver fat. Similar results were observed after adjustment for subcutaneous or visceral fat depots when tested individually or simultaneously in the model. Conclusion Our study suggested a protective role of adiponectin against incident hypertension independent of body fat distribution.
Peri-Okonny et al. (Mon,) studied this question.